Funds · VRTX

Who owns VRTX?

Institutional ownership of Vertex Pharmaceuticals Incorporated from Form 13F, Q2 2026

1,754 institutional managers reported holding Vertex Pharmaceuticals Incorporated (VRTX) in Form 13F filings for Q2 2026, with 242,243,526 shares worth $120B. The largest reported holder was Capital World Investors. Managers that filed both quarters added a net 10,540,341 shares (+4.6%). 171 opened new positions and 108 sold out.

Funds holding
1,754
Value held
$120B
New / sold out
171 / 108
Net shares, same filers
+4.6%

Holdings as of June 30, 2026, the end of Q2 2026. Managers have 45 days after a quarter ends to file Form 13F (by August 14, 2026 for Q2 2026), so positions may have changed since.

Largest holders of VRTX

FundValueShare of 13F holdingsSharesMove
Capital World Investors$13.0B10.8%26,115,014Added
BlackRock, Inc.$12.0B10.0%24,109,373Added
Capital Research Global Investors$9.7B8.0%19,490,637Trimmed
Vanguard Capital Management LLC$8.2B6.8%16,580,713Added
State Street Corp$5.9B4.9%11,871,459Added
Invesco Ltd.$4.0B3.3%8,043,052Added
JPMorgan Chase & Co$3.3B2.7%6,517,600Trimmed
Geode Capital Management, LLC$3.0B2.5%6,017,848Trimmed
Vanguard Portfolio Management LLC$2.4B2.0%4,878,987Trimmed
Capital International Investors$2.3B1.9%4,695,144Trimmed
Loomis Sayles & Co L P$1.9B1.6%3,920,953Trimmed
Franklin Resources Inc$1.7B1.4%3,347,253Added
Wellington Management Group LLP$1.6B1.3%3,247,658Added
Morgan Stanley$1.6B1.3%3,242,139Added
UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC$1.5B1.3%3,086,683Added
Bank of America Corp$1.5B1.3%3,039,178Added
Jennison Associates LLC$1.5B1.2%2,998,530Added
Norges Bank$1.5B1.2%2,971,681New
Alliancebernstein L.p.$1.3B1.2%3,019,315Trimmed
Ameriprise Financial Inc$1.3B1.1%2,604,822Trimmed
Northern Trust Corp$1.2B1.0%2,486,478Trimmed
Goldman Sachs Group Inc$1.2B1.0%2,481,761Added
Clearbridge Investments, LLC$1.2B1.0%2,342,915Trimmed
Victory Capital Management Inc$1.1B0.9%2,173,152Added
Charles Schwab Investment Management Inc$1.0B0.8%2,041,282Added

Share of 13F holdings is each fund's shares as a share of the 242,243,526 VRTX shares all 13F filers reported, not of shares outstanding.

The change in shares since the quarter before, adjusted for stock splits and priced at the Q2 2026 value per share. Funds bought $10.3B and sold $5.1B; 689 added and 609 trimmed.

Questions about VRTX ownership

Who owns VRTX stock?
1,754 institutional investment managers reported VRTX positions in their Form 13F filings for Q2 2026, holding 242,243,526 shares worth $120B in total. Capital World Investors reported the largest position.
Are funds buying or selling VRTX?
In Q2 2026, 171 managers opened new VRTX positions, 689 added, 609 trimmed and 108 sold out. Managers that filed in both quarters added a net 10,540,341 shares.
How current is this VRTX institutional ownership data?
It covers holdings as of the end of Q2 2026. Managers have 45 days after the quarter ends to file Form 13F (by August 14, 2026 for Q2 2026), so positions may have changed since.

From the SEC's Form 13F data sets for Q2 2026: every 13F holdings report, matched to VRTX by CUSIP. Options are left out. VRTX news and filings · VRTX insider trades · Top funds